Fevara – interims, was it ramptastic ahead of the results?
Last week on company describing itself as “an international specialist in livestock supplements” Fevara (FVA), with the shares at 136.5p I reviewed an argued “significant potential” new partnership including asking if it attempted ramptastic ahead of the company’s half-year ended 28th February 2026 results. What about now those results, and the shares currently at 127p?


